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The VD Fact Sheet Is intended as a handy source of basic statistics on the venereal
diseases in the United States, In this booklet, public health specialists, students, physicians,
and other persons interested in medical data will find venereal diseases measured by incidence
and prevalence. The general public will find tables showing the costs of uncontrolled venereal
disease and the frequency of psychoses and deaths from syphilis. While the results of case-
finding are measured in terms of cases reported, the actual amount of casefinding effort is
seen in the volume of diagnostic examinations and epidemiologic activity. As there is no agent
for immunizing the population, finding and treating cases continues to be the only feasible means
of controlling venereal disease.
Facts on these aspects of the venereal disease problem and program are presented In the
text and tables which follow. The information is current as of the date of publication, and it
supersedes any previously published data. Where no source is cited, the data presented are
based on the statisticscollectedby the Venereal Disease Program of the National Communicable
Disease Center, or upon estimates made by the Program. Where data are indicated as being
for “fiscal years,” the period runs from July 1 of the previous year through June 30 of the year
indicated on the table. Rates per 100,000 population shown in this Fact Sheet are based on
appropriate population estimates obtained from the Bureau of the Census.
1
Incidence
The Incidence of syphilis is defined as the number of new cases occurring in a given
area within a specified period of time, usually a year.
Since the symptoms of primary and secondary syphilis appear soon after the disease is
acquired, the number of primary and secondary cases occurring in the population within a given
period of time would be the same as the incidence of syphilis.
Cases of primary and secondary syphilis are reportable by law in all of the 50 States and
the District of Columbia. In the fiscal year ending Jime 30, 1966, physicians and clinics in the
United States reported 22,473 cases to State or local departments of health. But the number of
cases reported understates actual incidence for two reasons:
1. Not all cases are diagnosed, and
2. Not all diagnosed cases are reported.
In July 1962, the American Social Health Association, in cooperation with the American
Medical Association, the National Medical Association, and the American Osteopathic Associ-
ation sent a questionnaire to every private physician in the United States. One of the questions
asked was “How many new cases of primary and secondary (infectious) syphilis did you treat
between April 1 and June 30, 1962?”
One hundred and thirty-one thousand two hundred and forty-five responding physicians
indicated they treated 13,930 cases of infectious syphilis during these three months (an esti-
mate of 55,720 cases for the year 1962), These 55,720 cases plus 13,769 cases of infectious
S3q)hllis treated in 1962 by public clinics (not included in the survey) total an estimated 69,489
newly acquired cases of syphilis treated. Actually, 69,489 cases can be considered minimum
incidence since it does not include cases treated by physicians who failed to respond to the
survey nor cases occurring but not detected during the year. This estimate is presented only
to show that the actual incidence of syphilis is much higher than reported new cases. In fact,
if one considers that at least half of the cases occurring are not detected until the late or latent
stages of disease, then the actual annual incidence of syphilis would be at least twice the esti-
mated 69,489 cases treated in 1962,
2
Costs of Uncontrolled Syphilis
The statistics presented in Table 1 (next page) indicate the toll Imposed by syphilis upon
the manpower and economy of the country.
The estimate of man-years of disability for Institutionalization of the syphilitic Insane is
based on the total number of patients in mental Institutions and upon the proportion of those
diagnosed as having syphilitic psychoses. Patients in State, coimty, and Veterans Administration
hospitals for the permanent care of the insane are Included.
The cost of maintenance is based upon the number of patients with syphilitic psychoses
in tax supported institutions and upon the average per patient maintenance cost. Approximately
three percent of patients with syphilitic psychoses are maintained in private institutions and
these have not been Included in this report.
Disability attributed to cardiovascular syphilis and to locomotor ataxia is based on
conservative estimates of the prevalence of these late manifestations of syphilis.
The loss of life expectancy Indicates the loss of future years of life for persons dying of
syphilis in 1964. It is based on the expected years of life remaining to persons of that age, color
and sex. The loss of income is based on projected earnings of these persons for the productive
years of life lost to age 65. The estimated earnings are based on the median total money income
rate for adults for 1964.
While disabilities and deaths from syphilis have been diminishing in recent years, costs
and losses per case have been rising. Asa result, total costs and income losses from syphilitic
disabilities and deaths remain high compared to previous estimates.
On the basis of findings of research conducted in Macon County, Alabama, it has been
estimated that the life expectancy of a Negro male between the ages of 25 and 60 years, infected
with syphilis and receiving no appreciable treatment for his infection, is reduced by about 17
percent.*
*Shafer, J.K.; Usilton, Lida J.; Glecson, Geraldine A.: Untreated Syphilis in the Male NcRro: A prospective study




ESTIMATED ANNUAL COSTS OF UNCONTROLLED SYPHILIS
UNITED STATES, 1964*
HAN-YEARS OF SYPHILIS DISABILITY PER YEAR
Institutionalization for syphilitic insanity ...o, » 17,100
Disability from cardiovascular syphilis including aneurysm ...... 8,100
Disability from tabes dorsalis 100
Disability from syphilitic blindness • 6,000
ECONOMIC COSTS OF SYPHILITIC PSYCHOSES
-^ND SYPHILITIC BLINDNESS PER YEAR
Maintenance of patients with syphilitic psychoses $46,424,000
Compensation to syphilitic blind $ 6,192,000





Total population .... 40,789
LOSS OF INCOME TO AGE 65 AT 1964 MEDIAN TOTAL MONEY INCOME RATE $41,158,000
^Estimates based on most recent year (1964) for which data is available.
4
Reported Mortality and Insanity
Due to Syphilis
Mortality statistics are processed and tabulated in the National Center for Health
Statistics (NCHS) from microfilm copies of the original certificates filed with State or local
registrars. Mortality rates for syphilis are calculated by dividing the number of deaths In a given
year by the population for that year and multiplying by 100,000 (rate per 100,000 population).
The Infant mortality rate for syphilis for a given year is obtained by dividing the number
of deaths due to syphilis among children under one year of age by the number of live births
in the year multiplied by 10,000 (rate per 10,000 live births).
Since deaths from sj^hllis represent casefinding and treatment failures, mortality due to
syphilis may be considered an Inverse measure of the success of the syphilis control program.
It has been the practice since 1900 to revise the International Lists of Diseases and Causes
of Death about every 10 years to keep abreast of medical progress. These revisions have at
times affected the continuity of syphilis mortality statistics. “The Sixth Revision of the Inter-
national Lists of Causes of Death,” which became effective in 1949, reduced reported syphilis
deaths by about 26 percent. In “The Seventh Revision of the International Lists of Causes of
Death,” which was published in 1955 and became effective beginning January 1958, an increase
of 3.3 percent for syphilis and its sequelae occurred by reason of a change in interpretation
of “aneurysm of the aorta” reported in a sequence involving arteriosclerosis of sites other than
the aorta. It should be noted, however, that the interpretation of such sequences reverted in
1959 to that used with the Sixth Revision. Mortality rates given in this FACT SHEET have been
adjusted to the basis of the Seventh Revision, No adjustment was made for infant mortality
since it was affected very little by changes in the Seventh Revision.
Insanity due to syphilis is measured by the rate of first admissions to mental hospitals
because of syphilis. Excluded are first admissions to psychopathic hospitals which provide only
temporary care, and admissions to V'eterans Administration facilities. The number of admis-
sions is obtained from “Patients in Mental Institutions” published by the National Institute
of Mental Health. Since only first admissions are included in the rate, the figures over a period
of years represent a measure of the trend of incidence of syphilitic insanity.
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Reported Cases of Venereal Disease
All States require that each case of syphilis and gonorrhea which comes to medical
attention must be reported to the State or local health officer. The other venereal diseases
are also reportable in most States, Every three months, each State submits to the Public
Health Service a statistical summary of cases reported during the quarter. All cases not
previously reported in the State, regardless of duration of Infection or treatment status, are to
be counted in the statistical report of cases. Reported morbidity, as reported cases are some-
times called, indicates the volume of successful casefinding.
The trend of reported cases or case rates of early syphilis over a period of years may be
indicative of incidence trends if no significant changes in casefinding efforts or completeness
of case reporting have occurred. Similarly, the trend of reported cases of syphilis in all stages
of disease can be Interpreted as indicative of prevalence trends subject to the limitations
Imposed by changes in casefinding efforts and completeness of case reporting. For these
reasons, trends in reported cases and rates must be Interpreted with caution since changes
in casefinding efforts and completeness of case reporting are reflected in morbidity data just
as much as changes in disease Incidence and prevalence.
Reported venereal disease cases and rates are shown in Tables 3 through 9. Of particular
recent Interest is the slight decrease in primary and secondary syphilis cases which occurred
in Fiscal Year 1966 after eight successive years of Increases, the increases measuring as much
as 50 percent per year in the years 1960 and 1961.
The differences in reported cases and rates between color groups as shown in Table 5
may be biased because nonwhites tend to utilize public diagnostic and treatment facilities where
reporting is complete and whites tend to seek treatment at private diagnostic facilities where
reporting is not complete.
The trend of reported cases of congenital syphilis by age is shown In Table 6, and Tables
7 and 8 show age specific cases and rates by color and sex for primary and secondary syphilis
and for gonorrhea.
TABLE 3
CASES OF SYPHILIS AND GONORRHEA













Fiscal ALL STAGES OF SYPHILIS GONORRHEA
Year Cases Rates Cases Rates
1919 100,466 113o2 131,193 147.8
1920 142,869 145.3 172,387 175.4
1921 184,090 172.3 189,927 177.7
1922 171,824 157.7 152,959 140.4
1923 172,258 156.2 156,826 142.2
1924 194,936 174.2 161,676 144.5
1925 201,692 181.2 166,208 149.3
1926 205,595 196.1 164,808 157.2
1927 196,457 171.9 160,793 140.7
1928 185,437 174.2 147,219 138.3
1929 195,559 169.2 156,544 135.4
1930 213,309 185.4 155,875 135.5
1931 229,720 197.4 155,895 134.0
1932 242,128 208.2 154,051 132.5
1933 238,656 193.4 149,823 121.4
1934 231,129 186o7 153,542 124.1
1935 255,856 205.6 162,763 130.8
1936 267,717 212.6 163,465 129.8
1937 336,258 264.3 182,460 143.4
1938 480,140 372.0 198,439 153.8
1939 478,738 367.1 182,314 139.8
1940 472,900 359.7 175,841 133.8
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REPORTED VENEREAL DISEASE CASES AND CASE RATES PER 100,000 POPULATION*
UNITED STATES











Cases Rates Cases Rates Cases Rates Cases Rates
Alabama 1,928 56.1 1,252 36.4 4,056 118.0 45 1.3
Alaska 32 14.6 7 3,2 1,040 470.6 0 -
Arizona 561 35.4 201 12.7 3,158 199.1 10 .6
Arkansas 1,257 64.5 152 7.8 6,064 311.0 11 .7
California 11,726 64.1 1,768 9.7 40,243 220.0 77 .4
Colorado 509 26.4 59 3.1 2,195 113.6 5 .3
Connecticut 644 22.8 103 3.7 2,762 97.9 3 .1
Delaware 517 104.0 46 9.3 1,100 221.3 3 .6
Dist. of Columbia 1,473 186.7 468 59.3 9,941 1259.9 381 48.3
Florida 6,320 110.6 2,103 36.8 10,619 185.9 265 4 .
6
Georgia 2,526 59.2 1,014 23.8 12,149 285.0 117 2.7
Hawaii 130 20.1 35 5.4 402 62.0 5 .8
Idaho 17 2.4 9 1.3 1,049 152.9 2 .3
Illinois 7,188 67.8 1,260 11.9 31,153 294.0 12 .1
Indiana 1,075 22.0 76 1.6 4,540 93.1 4 .1
Iowa 851 30.9 72 2.6 2,873 104.2 5 . 1
Kansas 977 44.5 62 2.8 2,798 127.5 2 .1
Kentucky 1,723 54.8 125 4.0 3,455 110.0 16 .5
Louisiana 2,869 81.8 649 18.5 5,509 157.4 63 1.8
Maine 279 28.6 4 .4 402 41.2 0 -
Maryland 3,243 93.7 555 16.0 6,741 194.7 13 .4
Massachusetts 1,787 33.6 331 6.2 4,401 82.9 5 .1
Michigan 5,784 70.7 1,057 12.9 14,765 180.1 130 1.5
Minnesota 204 5.8 56 1.6 2,187 61.6 2 .1
Mississippi 951 41.3 647 28.1 4,401 191.3 35 1.5
Missouri 3,503 78.4 214 4.8 8,622 192.9 54 1.2
Montana 145 20.8 35 5.0 473 68.0 2 .2
Nebraska 373 25.6 78 5.3 1,080 74.0 1 .1
Nevada 231 53,5 32 7.4 687 159.0 1 .2
New Hampshire 79 11.9 14 2.1 296 44.7 5 .8
New Jersey 3,943 58.5 828 12.3 4,016 59.6 13 .1
New Mexico 942 93.5 101 10.0 1,567 155.6 2 .2
New York 18,866 104.7 3,329 18.5 37,889 210.2 98 .5
North Carolina 2,242 46.5 976 20.2 10,318 214.0 87 1.8
North Dakota 19 3.1 5 .8 442 69.1 0 -
Ohio 4,277 41.9 623 6.1 14,527 142.1 26 .3
Oklahoma 1,204 49.3 110 4.5 3,446 140.8 8 .3
Oregon 362 19.2 55 2.9 2,532 133.7 3 .2
Pennsylvania 4,961 43.1 567 4.9 8,790 76.4 23 .2
Rhode Island 348 38.9 31 3.5 359 40.1 0 -
South Carolina 1,742 70.0 882 35,5 7,121 286.2 22 .8
South Dakota 115 16.5 36 5.2 659 94.7 1 .1
Tennessee 1,389 36.4 342 9.0 9,962 261.1 36 1.0
Texas 5,528 53.2 1,544 14.9 28,560 275.0 105 1.0
Utah 139 14.1 18 1.8 427 43.4 0 -
Vermont 21 5.3 2 .5 208 52.4 2 .5
Virginia 1,972 45.9 296 6.9 8,060 187.7 28 .7
Washington 251 8.6 48 1.6 3,449 117.8 5 .2
West Virginia 1,436 79.2 100 5.5 934 51.6 3 .2
Wisconsin 1,368 33.1 89 2.1 2,362 57.1 3 .1
Wyoming 101 30.2 7 2.1 160 47.8 0
United States Total 110,128 57.1 22,473 11.6 334,949 173.6 1,739 .9
*Rates less than .05 not shown.
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Casefinding investigations fall into two categories: (1) the investigation of sex contacts
of patients with recently acquired and infectious disease, and (2) the investigation of persons
other than sex contacts who are suspected of having venereal disease. Most of the latter
group of suspects are persons with reactive tests for syphilis which are generated by the
estimated 38,000,000 serologic tests performed annually in the United States, and are referred
to in Table 10 as positive diagnostics. Thousands of the investigations of positive diagnostics
and sex contacts carry health department casefinding workers into the offices of private
physicians who make the medical determination of whether or not the suspects have syphilis.
For many years, the proficiency of the interviewing-contact investigation process in
ferreting out the foci of syphilis infections in the community has been measured by a series
of epidemiologic Indices. The indices presented in Table 10 are based only on infectious cases
diagnosed in health department clinics and do not Include cases diagnosed and reported by
private physicians. These indices are defined as follows:
The Contact Index is the average number of sex contacts elicited per infectious (primary
and secondary) syphilis case interviewed.
The Epidemiologic Index is the average number of cases of syphilis identified per infec-
tious case interviewed. A number of these identified cases will already have been diagnosed
and treated.
The Brought-to-Treatment Index is the average number of previously not diagnosed cases
of syphilis brought to treatment per Infectious case interviewed.
The Lesion- to -Lesion Index is the average number of infectious (lesion or primary or
secondary) cases brought to treatment per infectious case interviewed.
TABLE 10
HEALTH DEPARTMENT CASEFINDING ACTIVITIES, UNITED STATES
FISCAL YEARS 1961-1966
1961 1962 1963 1964 1965 1966
Number of positive diag-
nostics investigated. 239,835 234,305 243,257 241,016 245,715 257,009




225,541 186,784 179,715 192,580 186,386 183,634
Contact Index 4.10 4.03 3.98 3.86 3.69 3.59
Epidemiologic Index 1.22 1.24 1.17* 1.13* 1.11* 1.13*
Brought-to-Treatment Index .55 .52 .47* .46* .45* .45*
Lesion-to- Lesion Index .33 .32 .30 .31 .32 .30




Recommended treatment for early congenital syphilis (less than 2 years) consists of
aqueous procaine penicillin G in total dosage of 100,000 ///kg, in 10 equally divided daily doses.
Late congenital syphilis is treated with the same schedules as for comparable manifestations
of acquired syphilis.
The earlier penicillin therapy is Instituted for congenital syphilis, the more satisfactory
the results.
Early Syphilis
Benzathine penicillin G and procaine penicillin G in oil with 2-percent aluminum mono-
stearate (PAM) are the most widely used penicillin preparations for the treatment of early
syphilis. Since benzathine penicillin G maintains a detectable blood level for a much longer
period of time than PAM, a smaller total dosage is required for satisfactory results. The
recommended schedules are 2,400,000 units of benzathine penicillin G administered in a single
session (1,200,000 units in each buttock) or 4,800,000 units of PAM, 2,400,000 units at first
session, and subsequent injections of 1,200,000 units given at 2- or 3-day Intervals, If aqueous
procaine penicillin G is used, 600,000 units should be administered daily for 8 days to total
4,800,000 units.
For the patient who is sensitive to penicillin, erythromycin (20-30 grams) or tetracycline
(30-40 grams) is recommended for the treatment of syphilis.
Epidemiologic Treatment
The treatment of all sex contacts of patients with early infectious syphilis is recom-
mended as the most effective procedure for preventing the spread of syphilis. Although clinically
and serologically negative at time of initial examination, some of these contacts will have
incubating S3rphilis and some, particularly females who may have an inconspicuous or no
primary lesion, will already have developed syphilis. It is suggested, therefore, that contacts
be treated for syphilis (rather than for incubating syphilis) with a dosage of 2,400,000 units of
benzathine penicillin G,
Syphilis in Pregnancy
Congenital syphilis is completely preventable. Adequate treatment of the mother during
the first 18 weeks of gestation prevents infection of the baby; adequate treatment after the 18th
week cures the baby in utero.
In two studies, comprising 528 Infants born to treated S3qjhilitic mothers, approximately
98 percent of the children were nonsyphilitic. The percentage varied slightly by stage of
mother’s syphilis during pregnancy.
In the absence of relapse or reinfection, a woman treated with penicillin for syphilis
will not require further treatment in the event of pregnancy.
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Neurosyphilis
A cooperative study conducted by the Public Health Service and leading neurosyphllolo-
gists in the United States has demonstrated that penicillin is the most effective treatment yet
known for neurosyphilis.
Asymptomatic Neurosyphilis — Among 765 patients with asymptomatic neurosyphilis,
approximately 75 percent of whom were treated with a minimum of 4,800,000 units of penicillin,
only one bona fide progression to symptomatic neurosyphilis was observed; 11 other patients
exhibited minor neurologic changes. In contrast, among 467 patients treated with metal chemo-
therapy, 29 progressed to symptomatic neurosyphilis and an additional 15 showed minor neuro-
logic changes.
Paresis —- Six hundred and twenty-nine patients were treated for paresis with penicillin
only, 60 percent of whom received a minimum of 6,000,000 units. Paresis was diagnosed severe
in 330, moderately severe in 141, and mild in 158. Five years after treatment 42 percent of
those with severe psychoses were in remission or showed significant improvement, 45 per-
cent remained unchanged, and only 13 percent had progressed or died from paresis. Progres-
sion or death from paresis occurred in 7.0 percent of those with moderately severe psychosis
and in less than one percent of those with mild psychosis. Further proof of the effectiveness of
penicillin is the fact that among those who survived, one-third of those who had been in-
stitutionalized, and two- thirds of those who had been unable to work at time of treatment were
gainfully employed 5 years later.
The total recommended dosage of penicillin for both symptomatic and asymptomatic
neurosyphllls is 6,000,000 to 9,000,000 units. Any benefit from more than 10,000,000 units is
doubtful and has not been demonstrated. Treatment schedules are as follows:
Benzathine penicillin G — 3,000,000 units at 7-day intervals.
PAM — 1,200,000 units at 3-day intervals.
Aqueous procaine penicillin G — 600,000 units dally.
Treatment of Gonorrhea
The treatment of gonorrhea is in a state of uncertainty although penicillin still remains
the drug of choice. Some strains of the gonococcus are developing increasing resistance to
penicillin, but this resistance is relative and not absolute. As a result it is necessary to rec-
ommend on an interim basis short acting penicillin preparations in larger doses. Treatment
schedules are presently being evaluated and until results are available the following are
recommended:
Uncomplicated gonorrhea in men: Aqueous procaine penicillin G, 2,400,000 units in one
IM injection.
Uncomplicated gonorrhea in women: Aqueous procaine penicillin G, 4,800,000 units IM in
two injection sites at one visit, or the combination of aqueous procaine penicillin G and pro-
caine penicillin G in oil with 2 percent aluminum monostearate for two separate IM injections
of 2,400,000 units in each site given at one visit.
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Prophylactic or epidemiologic treatment for gonorrhea (male and female) is accomplished
with the same treatment schedules as for uncomplicated gonorrhea.
Treatment of gonorrhea with severe complications must be individualized using large
amounts of short acting penicillin.
Excluding the likelihood of reinfection, retreatment is indicated if the discharge in un-
complicated male gonorrhea persists for three or more days following initial therapy and the
smear, F.A., or culture is still positive. In uncomplicated gonorrhea in the female retreatment
is indicated if followup cultures or F. A, procedures remain positive for gonococci. Retreatment
consists of doubling the original dosage at a single visit or in divided doses on two successive
days.
Gonorrhea patients sensitive to penicillin may be treated effectively with tetracycline,
erythromycin, or oleandomycin. These may be administered as a single oral dose of 1.5
grams or 0.5 gram given orally every 4-6 hours until 2-3 grams have been given.
Gonorrhea patients who are sexual contacts to infectious syphilis should be given full
prophylactic therapy for syphilis (2,400,000 units of benzathine penicillin G) as well as recom-
mended therapy for gonorrhea. While long acting forms of penicillin (such as benzathine
penicillin) are ideal in syphilotherapy, they are not indicated in routine gonorrhea treatment.
Penicillin Reactions
Since penicillin is the drug of choice for the treatment of both syphilis and gonorrhea, the
Venereal Disease Program is concerned with the frequency and severity of reactions to
penicillin therapy. Through the cooperation of venereal disease clinics three studies at 5-year
intervals (1954, 1959 and 1964) have been conducted to determine their frequency.
The 1959 and 1964 studies were patterned after the 1954 study, the single departure
being a request that, if possible, patients be detained in the clinic for a 30-minute period
following treatment. Reactions to penicillin were reported in 5.9/1,000 patients treated in
1954, in 9,7/1,000 treated in 1959, and in 8,0/1,000 treated in 1964. The increase over 1954 is
attributed mainly to the delay in dismissing patients after treatment.
In each study, urticaria was the most frequent type of reaction, occurring in from
4-6/1,000 patients treated. Moderate to severe anaphylaxis was observed in 0.21 to 0.35/1,000
patients. The only death reported during a study period occurred in 1964,
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